Abeona Therapeutics(R) Closes Sale of Rare Pediatric Disease Priority Review Voucher for $155 Million
Abeona Therapeutics(R) Closes Sale of Rare Pediatric Disease Priority Review Voucher for $155 Million Cash resources totaled approximately $225 million as of June 30, 2025 GlobeNewswire July 02, 2025 CLEVELAND, July 02, 2025 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced the closing of the sale of its Rare Pediatric Disease Priority Review […]